Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T-cell receptor (TCR) beta variable (Vβ) chain is a polymorphic protein component of the αβ TCR complex found on the majority of T-lymphocytes. It plays a fundamental role in the adaptive immune system by facilitating the recognition of peptide antigens presented by Major Histocompatibility Complex (MHC) molecules (StatPearls). The diversity of the Vβ repertoire, generated through V(D)J recombination, allows for the detection of a wide range of pathogens and malignant cells (UniProt). In clinical contexts, specific Vβ chains are targeted by bacterial superantigens, such as Toxic Shock Syndrome Toxin-1 (TSST-1), which bypass traditional antigen processing to cause massive, non-specific T-cell activation and systemic inflammation (Nature Reviews Immunology). Therapeutically, monoclonal antibodies directed against specific Vβ families are being investigated to selectively deplete malignant T-cell clones in lymphomas or pathogenic T-cells in autoimmune diseases like multiple sclerosis (Frontiers in Immunology). Monitoring the Vβ repertoire serves as a vital biomarker for assessing immune reconstitution after bone marrow transplantation and for diagnosing T-cell clonality (Journal of Clinical Investigation). However, targeting these chains carries risks, including severe cytokine release syndrome and the potential for broad immunosuppression if multiple Vβ families are affected (Nature Reviews Immunology).
Binding to the variable region of the T-cell receptor beta chain to induce T-cell activation, depletion, or modulation of specific T-cell subsets.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor beta variable chain (TRBV).